Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederclinicaltrials.gov
Get the latest updates from ClinicalTrials.gov: Obesity and Overweight OR Type 2 Diabetes | Interventional studies | Funded by Industry | Last update posted in the last 14 days directly as they happen.
Follow now < 10 followers
Last updated about 22 hours ago
4 days ago
Conditions: Obesity, Primary Interventions: Device: g-Cath EZ Delivery Catheter with Snowshoe Suture...
4 days ago
Conditions: Obesity or Overweight Interventions: Drug: Petrelintide; Combination Product: Enicepatide; Drug: Petrelintide-matching...
4 days ago
Conditions: Overweight; Obesity Interventions: Drug: Macupatide; Drug: Eloralintide; Drug: Placebo Sponsors: Eli...
4 days ago
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: AMG 127; Drug: Placebo Sponsors...
4 days ago
Conditions: Overweight; Obesity Interventions: Drug: Cagrilintide; Drug: Placebo Cagrilintide Sponsors: Novo Nordisk...
4 days ago
Conditions: Overweight,Obesity Interventions: Drug: ZT002 injection, metformin, warfarin; Drug: ZT002 injection, rosuvastatin...
4 days ago
Conditions: Prader-Willi Syndrome Interventions: Drug: CSTI-500 Sponsors: ConSynance Therapeutics Recruiting
4 days ago
Conditions: Healthy Participants Interventions: Drug: AZD5004; Drug: Mitiglinide; Drug: Pioglitazone Sponsors: AstraZeneca...
4 days ago
Conditions: T2DM Interventions: Drug: CT-L03 Group 1; Drug: CT-L03 Group 2; Drug...
4 days ago
Conditions: Diabete Type 2; Hypertension Interventions: Drug: ATB-U101; Drug: ATB-1011; Drug: ATB-U1011...
4 days ago
Conditions: Obesity; Overweight; Osteoarthritis, Knee Interventions: Drug: NNC0487-0111; Drug: Placebo (matched to...
5 days ago
Conditions: Overweight; Obesity Interventions: Drug: Eloralintide; Drug: Placebo Sponsors: Eli Lilly and...